| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 811 |
FITC/CY3/CY5/CY7REDV多肽修饰双亲载体 |
566 |
hao |
2022-12-02 |
| 812 |
FITC/CY3/CY5/CY7APARPAR多肽/血管生成K237多肽/EGFR靶向多肽(ETP) |
506 |
hao |
2022-12-02 |
| 813 |
FITC/CY3/CY5/CY7HER2特异性亲和的短肽(命名为HE2)/HSNGLPL多肽/血糖素样肽-1(GLP-1) |
690 |
hao |
2022-12-02 |
| 814 |
FITC/CY3/CY5/CY7含D-脯氨酸甘氨酸多肽/OPN源性SVVYGLR多肽/HBV PreS1多肽 |
462 |
hao |
2022-12-02 |
| 815 |
FITC/CY3/CY5/CY7HN-1多肽/G3-C12多肽/卵泡刺激素多肽 |
456 |
hao |
2022-12-02 |
| 816 |
FITC/CY3/CY5/CY7K237多肽/TAT和NLS多肽/内皮细胞特异性靶向性肽REDV |
523 |
hao |
2022-12-02 |
| 817 |
FITC/CY3/CY5/CY7Jeko-1靶向多肽/REDV多肽/GnRH多肽/CLV3十二肽 |
449 |
hao |
2022-12-02 |
| 818 |
FITC/CY3/CY5/CY7GRGDSPC多肽/多肽P17/R8GD多肽 |
505 |
hao |
2022-12-02 |
| 819 |
FITC/CY3/CY5/CY7CAG多肽/糖蛋白衍生多肽RVG29/TAT-NLS多肽/ZS-1多肽 |
511 |
hao |
2022-12-02 |
| 820 |
FITC/CY3/CY5/CY7GE11多肽/CAGW多肽/源于白细胞介素13的多肽IP |
487 |
hao |
2022-12-02 |
| 821 |
FITC/CY3/CY5/CY7富精氨酸多肽RRRRRRRR(R8)/R8多肽 |
481 |
hao |
2022-12-02 |
| 822 |
FITC/CY3/CY5/CY7胶原多肽/多肽CALNN/PT多肽/CAG多肽 |
498 |
hao |
2022-12-02 |
| 823 |
FITC/CY3/CY5/CY7血管生成多肽PESV/鹿茸多肽(piloseantlerpolypeptide,PAP) |
528 |
hao |
2022-12-02 |
| 824 |
FITC/CY3/CY5/CY7多肽--32肽和21肽/β-淀粉样多肽 |
469 |
hao |
2022-12-02 |
| 825 |
FITC/CY3/CY5/CY7转移靶向肽(TMT)/穿膜肽TAT/Gly-Gly-Tyr-Arg四肽 |
463 |
hao |
2022-12-02 |
| 826 |
FITC/CY3/CY5/CY7CPPs/TAT穿膜肽/细胞穿膜肽CPPs/TAT/R8 |
453 |
hao |
2022-12-02 |
| 827 |
FITC/CY3/CY5/CY7TMTP1多肽/PH1多肽/BmKCT多肽/多功能肽TNCP/R5多肽 |
500 |
hao |
2022-12-02 |
| 828 |
FITC/CY3/CY5/CY7多肽polypeptid/多肽Ac-KAAAAAACF-CONH2/多肽GnRH |
514 |
hao |
2022-12-02 |
| 829 |
FITC/CY3/CY5/CY7血管再生性多肽/多靶点抗血管新生肽ES2-AF |
674 |
hao |
2022-12-02 |
| 830 |
FITC/CY3/CY5/CY7TRP-PK1-iRGD多肽/多肽C16Y/DEVDK多肽 |
473 |
hao |
2022-12-02 |
| 831 |
FITC/CY3/CY5/CY7微酸环境靶向多肽/穿膜肽CPP/**肽/靶向多肽CP |
489 |
hao |
2022-12-02 |
| 832 |
FITC/CY3/CY5/CY7pH响应肽和氧化还原敏感肽 |
458 |
hao |
2022-12-02 |
| 833 |
FITC/CY3/CY5/CY7组织蛋白酶响应肽和豆蛋白酶响应肽 |
502 |
hao |
2022-12-02 |
| 834 |
FITC/CY3/CY5/CY7基质金属蛋白酶响应肽和凋亡酶响应肽 |
517 |
hao |
2022-12-02 |
| 835 |
FITC/CY3/CY5/CY7亚细胞器靶向肽和基质金属蛋白酶响应肽 |
486 |
hao |
2022-12-02 |
| 836 |
FITC/CY3/CY5/CY7细胞靶向肽/微环境靶向肽/细胞膜靶向肽 |
509 |
hao |
2022-12-02 |
| 837 |
FITC/CY3/CY5/CY7多肽类抗生素/多肽生长因子/阳离子多肽/血管靶向肽GX1 |
435 |
hao |
2022-12-02 |
| 838 |
FITC/CY3/CY5/CY7多肽疫苗/多肽药物/多肽激素 |
418 |
hao |
2022-12-02 |
| 839 |
FITC/CY3/CY5/CY7免疫活性肽/神经活性肽/其他活性肽/生物活性多肽 |
440 |
hao |
2022-12-02 |
| 840 |
FITC/CY3/CY5/CY7多肽合成用树脂/抗菌性活性肽/细胞因子模拟肽 |
418 |
hao |
2022-12-02 |
| 841 |
FITC/CY3/CY5/CY7化妆品多肽/磷酸化多肽/抗菌肽/生物抗菌肽 |
472 |
hao |
2022-12-02 |
| 842 |
FITC/CY3/CY5/CY7伪二肽/穿膜肽/药物多肽中间体 |
621 |
hao |
2022-12-02 |
| 843 |
FITC/CY3/CY5/CY7多肽类药物：多肽疫苗、抗多肽、抗病毒多肽、多肽导向药物、细胞因子模拟肽、抗菌性活性肽、诊断用多肽以及其他药用小肽等 |
548 |
hao |
2022-12-02 |
| 844 |
FITC/CY3/CY5/CY7GLP系列多肽 |
464 |
hao |
2022-12-02 |
| 845 |
FITC/CY3/CY5/CY7β-Amyloid 淀粉肽系列 |
454 |
hao |
2022-12-02 |
| 846 |
FITC/CY3/CY5/CY7血管紧张肽Angiotensin系列 |
548 |
hao |
2022-12-02 |
| 847 |
FITC/CY3/CY5/CY7线性肽/药物肽/美容肽/底物肽 |
498 |
hao |
2022-12-02 |
| 848 |
FITC/CY3/CY5/CY7一段29个氨基酸序列的多肽(命名为RVG29) |
436 |
hao |
2022-12-02 |
| 849 |
FITC/CY3/CY5/CY711.RVG29多肽 |
432 |
hao |
2022-12-02 |
| 850 |
FITC/CY3/CY5/CY710.细胞转运肽R8 |
462 |
hao |
2022-12-02 |
| 851 |
FITC/CY3/CY5/CY7c(RGDyV) cyclo(Arg-Gly-Asp-d-Tyr-Val) |
512 |
hao |
2022-12-02 |
| 852 |
FITC/CY3/CY5/CY7c(RGDyK) cyclo (Arg-Gly-Asp-d-Tyr-Lys) |
388 |
hao |
2022-12-02 |
| 853 |
FITC/CY3/CY5/CY7c(RGDyE) cyclo(Arg-Gly-Asp-D-Tyr-Glu) |
418 |
hao |
2022-12-02 |
| 854 |
FITC/CY3/CY5/CY7c(RGDyC) cyclo (Arg-Gly-Asp-D-Tyr-Cys) |
405 |
hao |
2022-12-02 |
| 855 |
FITC/CY3/CY5/CY7c(RGDfK) cyclo (Arg-Gly-Asp-d-Phe-Lys) |
436 |
hao |
2022-12-02 |
齐岳微信公众号
官方微信
库存查询